Clinical Trial
doi: 10.1136/pgmj.53.625.679.
A comparison of once and twice daily atenolol in hypertension
- PMID: 339214
- PMCID: PMC2496839
- DOI: 10.1136/pgmj.53.625.679
Item in Clipboard
Clinical Trial
A comparison of once and twice daily atenolol in hypertension
Postgrad Med J.
1977 Nov.
Abstract
The hypertensive action of atenolol has been studied in a randomized double-blind crossover comparison. Twelve patients showed a highly significant reduction in average supine systolic and diastolic blood pressures from pre-treatment values of 196.3/115.9 to 159.1/89.2 mmHg (26.1/15.4 kPa to 22.2/11.9 kPa) after 2 weeks on once daily atenolol. No dose-related reduction in blood pressure was seen and the single 100 mg daily dose was as effective as 100 mg twice daily or 50 mg twice daily. Blood pressures recorded after 2 weeks' atenolol were lower than those obtained at 7 days irrespective of dose.
Similar articles
-
Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.Eur J Clin Pharmacol. 1980 Nov;18(5):365-74. doi: 10.1007/BF00636787. Eur J Clin Pharmacol. 1980. PMID: 7002567
-
A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.Br J Clin Pharmacol. 1983 Jun;15(6):715-7. doi: 10.1111/j.1365-2125.1983.tb01555.x. Br J Clin Pharmacol. 1983. PMID: 6347229 Free PMC article. Clinical Trial.
-
Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.Postgrad Med J. 1977;53 Suppl 3:168-72. Postgrad Med J. 1977. PMID: 337271 Clinical Trial. No abstract available.
-
Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.Aust N Z J Med. 1979 Aug;9(4):374-81. doi: 10.1111/j.1445-5994.1979.tb04162.x. Aust N Z J Med. 1979. PMID: 389223 Clinical Trial.
-
Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.Eur Heart J. 1987 Dec;8 Suppl M:55-64. doi: 10.1093/eurheartj/8.suppl_m.55-a. Eur Heart J. 1987. PMID: 2967186 Clinical Trial.
Cited by
-
Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.Eur J Clin Pharmacol. 1980 Nov;18(5):365-74. doi: 10.1007/BF00636787. Eur J Clin Pharmacol. 1980. PMID: 7002567
-
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.Br Med J (Clin Res Ed). 1982 Nov 13;285(6352):1387-92. doi: 10.1136/bmj.285.6352.1387. Br Med J (Clin Res Ed). 1982. PMID: 6814568 Free PMC article. Clinical Trial.
-
Comparison of ocular hypotensive effects of 3 dosages of oral atenolol.Br J Ophthalmol. 1983 Oct;67(10):664-7. doi: 10.1136/bjo.67.10.664. Br J Ophthalmol. 1983. PMID: 6351901 Free PMC article. Clinical Trial.
-
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs. 1979 Jun;17(6):425-60. doi: 10.2165/00003495-197917060-00001. Drugs. 1979. PMID: 38096 Review.
-
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.Br Med J. 1978 Aug 5;2(6134):383-5. doi: 10.1136/bmj.2.6134.383. Br Med J. 1978. PMID: 28810 Free PMC article. Clinical Trial.
